It is a dual agonist peptide, meaning it works by activating two types of receptors that play key roles in regulating metabolic processes, specifically GLP-1 (glucagon-like peptide 1) and GIP (gastric inhibitory polypeptide) receptors
Makers of these drugs recommend having a conversation about the side effect profile and personalized risks with a health care professional before starting.
Gallbladder disease In patients with established gallbladder disease, the relative risks and benefits of a cholecystectomy or preventive treatment with ursodeoxycholic acid before starting GLP-1 receptor agonist therapy should be thoroughly discussed
At Better Med Spa, these medications are framed as tools , not cures
They were randomly assigned in a 2:1 ratio, to 68 weeks of treatment with semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
As a member of the Medical and Scientific Communications team, Sandra educates healthcare professionals and consumers on nutrition, supplements, and related health concerns
